QTREX Quantum (NASDAQ:QTEX) Shares Down 9.8% – Here’s What Happened

Shares of QTREX Quantum Ltd. (NASDAQ:QTEX) were down 9.8% during trading on Wednesday. The stock traded as low as $1.01 and last traded at $1.01. 3,134,224 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 8,220,546 shares. The stock had previously closed at $1.12.

Analyst Ratings Changes

QTEX has been the subject of a number of research analyst reports. Weiss Ratings lowered QTREX Quantum from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, October 9th. Wall Street Zen downgraded QTREX Quantum from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

QTREX Quantum Trading Down 9.8%

The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.62 and a current ratio of 2.00. The business has a fifty day moving average price of $1.10.

QTREX Quantum (NASDAQ:QTEX) last posted its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million for the quarter.

Insider Transactions at QTREX Quantum

In other QTREX Quantum news, CEO Dagi Ben-Noon acquired 168,894 shares of the business’s stock in a transaction that occurred on Monday, September 28th. The shares were bought at an average cost of $0.71 per share, with a total value of $119,914.74. Following the completion of the acquisition, the chief executive officer directly owned 3,646,133 shares in the company, valued at $2,588,754.43. This represents a 4.86% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have purchased 207,834 shares of company stock worth $181,275 over the last 90 days. Company insiders own 29.40% of the company’s stock.

About QTREX Quantum

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.